OpenVSafe by OpenVAERS
Search V-safe

6X5-15164-97421

2 vaccinations 4 coded responses 22 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
009 / PR
Registered
2021-04-07
Relationship
Self
Race
Other
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-04-07
    Registered in v-safe
  2. 2021-04-07
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-07
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  4. 2021-04-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness · Be unable to work
    Adult check-in
  9. 2021-04-14
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-04-21
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-28
    Dose 2 — Pfizer-BioNTech
  12. 2021-04-28
    Health check-in — day 0, dose 2
    Feeling: Fair · Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  13. 2021-04-29
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  14. 2021-04-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-05-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  16. 2021-05-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-05-05
    Health check-in — day 7, dose 2
    Feeling: Good · Headache · Be unable to do your normal daily activities
    Adult check-in
  18. 2021-05-12
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-05-19
    Survey response — day 21, dose 2
    MedDRA: Cough, Fatigue, Oropharyngeal pain, Rhinalgia, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Tiredness, cough with sore throat, and upper nose sharp pain (im guessing its the sinuses).
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-05-26
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-06-02
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-06-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-07-30
    Survey response — 3 months, dose 2
    MedDRA: Disturbance in attention, Muscle discomfort, Somnolence — Feeling: Good
    Free text: Higher than usual feelings of sleepiness and lack of concentration. Random muscular discomfort.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  24. 2021-10-29
    Survey response — 6 months, dose 2
    MedDRA: Diarrhoea, Faeces discoloured, Musculoskeletal discomfort, Ocular discomfort — Feeling: Good
    Free text: Most recently, 1) my stool came out green, 2) i had diarrhea for a day (very different weeks), some discomfort around the eyes, some discomfort in the joints of my hands.
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-04-28
    Survey response — 12 months, dose 2
    MedDRA: Disturbance in attention, Psychomotor hyperactivity, Somnolence — Feeling: Good · Be unable to work or attend school
    Free text: Sudden periods of hyperactivity, lack of focus, and/or drowsiness. Note: I have no way of identifying the cause. It does not last long and does not occur many times.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-07Pfizer-BioNTech
22021-04-28Pfizer-BioNTech

Free text

Release 8 — day 21, dose 2

2021-05-19

Symptoms: Tiredness, cough with sore throat, and upper nose sharp pain (im guessing its the sinuses).

Release 9 — 3 months, dose 2

2021-07-30

Symptoms: Higher than usual feelings of sleepiness and lack of concentration. Random muscular discomfort.

Release 10 — 6 months, dose 2

2021-10-29

Symptoms: Most recently, 1) my stool came out green, 2) i had diarrhea for a day (very different weeks), some discomfort around the eyes, some discomfort in the joints of my hands.

Release 11 — 12 months, dose 2

2022-04-28

Symptoms: Sudden periods of hyperactivity, lack of focus, and/or drowsiness. Note: I have no way of identifying the cause. It does not last long and does not occur many times.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough ✓ ✓ ✓
SDDiarrhoea · · ✓
SDDisturbance in attention ✓ · ✓
SDFaeces discoloured · · ✓
SDFatigue ✓ ✓ ✓
SDMuscle discomfort ✓ · ✓
SDMusculoskeletal discomfort · · ✓
SDOcular discomfort · · ✓
SDOropharyngeal pain ✓ ✓ ✓
SDPsychomotor hyperactivity · · ✓
SDRhinalgia ✓ ✓ ✓
SDRhinorrhoea ✓ ✓ ✓
SDSomnolence ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release